InvestorsHub Logo
icon url

XenaLives

01/11/17 10:53 PM

#87454 RE: blu_1 #87453

So they can dominate the Doepezil Generic market too????
icon url

gburgin

01/12/17 8:50 AM

#87486 RE: blu_1 #87453

"IR told me Anavex 2-73 is under patent for many years to come. They referred to a patent, but I think it was for the patent specific to melanoma."

If you want a specific answer for patent coverage of a particular use such as treating Alzheimers you have to be VERY specific with your question. If you asked "Is 2-73 under patent" they will answer "yes" as long as there is ANY protection for 2-73 in their current patent portfolio. Since they currently do have a "method of use" patent for 2-73 treating melanoma, the answer to your broad question is "yes". If you want to know specifically if they have protection for 2-73 as a mono-therapy for AD then you have to ask them that specific question. I have done so several times and the responses (or lack thereof) I've received has lead me to believe that orveko_inc's patent research and conclusions were correct. No point in repeating his detailed research in this post, anyone can find it if they want to, just google his id.

(I decided to come back since a late cleanup was done to a particular chain).